Literature DB >> 23423652

Methylphenidate treatment leads to abnormalities on krebs cycle enzymes in the brain of young and adult rats.

Gislaine Z Réus1, Giselli Scaini, Camila B Furlanetto, Meline O S Morais, Isabela C Jeremias, Lis Mairá Mello-Santos, Karolina V Freitas, João Quevedo, Emilio L Streck.   

Abstract

Studies have shown a relationship between energy metabolism and methylphenidate (MPH); however, there are no studies evaluating the effects of MPH in Krebs cycle. So, we investigated if MPH treatment could alter the activity of citrate synthase (CS), malate dehydrogenase (MD), and isocitrate dehydrogenase (ID) in the brain of young and adult Wistar rats. Our results showed that MPH (2 and 10 mg/kg) reduced CS in the striatum and prefrontal cortex (PF), with MPH at all doses in the cerebellum and hippocampus after chronic treatment in young rats. In adult rats the CS was reduced in the cerebellum after acute treatment with MPH at all doses, and after chronic treatment in the PF and cerebellum with MPH (10 mg/kg), and in the hippocampus with MPH (2 and 10 mg/kg). The ID decreased in the hippocampus and striatum with MPH (2 and 10 mg/kg), and in the cortex (10 mg/kg) after acute treatment in young rats. In adult rats acute treatment with MPH (2 and 10 mg/kg) reduced ID in the cerebellum, and with MPH (10 mg/kg) in the cortex; chronic treatment with MPH (10 mg/kg) decreased ID in the PF; with MPH (2 and 10 mg/kg) in the cerebellum, and with MPH at all doses in the hippocampus. The MD did not alter. In conclusion, our results suggest that MPH can alter enzymes of Krebs cycle in brain areas involved with circuits related with attention deficit hyperactivity disorder; however, such effects depend on age of animal and treatment regime.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423652     DOI: 10.1007/s12640-013-9383-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  42 in total

Review 1.  Synaptic and mitochondrial physiopathologic changes in the aging nervous system and the role of zinc ion homeostasis.

Authors:  Carlo Bertoni-Freddari; Eugenio Mocchegiani; Marco Malavolta; Tiziana Casoli; Giuseppina Di Stefano; Patrizia Fattoretti
Journal:  Mech Ageing Dev       Date:  2006-03-07       Impact factor: 5.432

2.  Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine.

Authors:  Gustavo Feier; Samira S Valvassori; Jéssica Lopes-Borges; Roger B Varela; Daniela V Bavaresco; Giselli Scaini; Meline O Morais; Monica L Andersen; Emilio L Streck; João Quevedo
Journal:  Neurosci Lett       Date:  2012-09-27       Impact factor: 3.046

3.  Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.

Authors:  Andrew A Nierenberg; Sachiko Miyahara; Tom Spencer; Stephen R Wisniewski; Michael W Otto; Naomi Simon; Mark H Pollack; Michael J Ostacher; Leslie Yan; Rebecca Siegel; Gary S Sachs
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

4.  Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats.

Authors:  Ana O Fagundes; Gislaine T Rezin; Francine Zanette; Eliane Grandi; Lara C Assis; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Int J Dev Neurosci       Date:  2006-12-22       Impact factor: 2.457

Review 5.  D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.

Authors:  D James Surmeier; Jun Ding; Michelle Day; Zhongfeng Wang; Weixing Shen
Journal:  Trends Neurosci       Date:  2007-04-03       Impact factor: 13.837

6.  Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum.

Authors:  T Chase; N Carrey; E Soo; M Wilkinson
Journal:  Neuroscience       Date:  2006-12-06       Impact factor: 3.590

7.  Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.

Authors:  Jonas Hannestad; Jean-Dominique Gallezot; Beata Planeta-Wilson; Shu-Fei Lin; Wendol A Williams; Christopher H van Dyck; Robert T Malison; Richard E Carson; Yu-Shin Ding
Journal:  Biol Psychiatry       Date:  2010-08-05       Impact factor: 13.382

8.  Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats.

Authors:  Karin M Gomes; Cecília G Inácio; Samira S Valvassori; Gislaine Z Réus; Carina R Boeck; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurosci Lett       Date:  2009-08-27       Impact factor: 3.046

9.  Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides.

Authors:  Martin Gluck; Julie Ehrhart; Elizabeth Jayatilleke; Gail D Zeevalk
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

10.  Age-related changes in H2O2 production and bioenergetics in rat brain synaptosomes.

Authors:  Seán M Kilbride; Jayne E Telford; Gavin P Davey
Journal:  Biochim Biophys Acta       Date:  2008-06-02
View more
  9 in total

1.  Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Mohammad Abdollahi; Mansour Heidari; Zahra Madjd
Journal:  Neurotox Res       Date:  2017-01-11       Impact factor: 3.911

2.  Methylphenidate Decreases ATP Levels and Impairs Glutamate Uptake and Na+,K+-ATPase Activity in Juvenile Rat Hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Mateus Grings; Bruna Zanotto; Daniella M Coelho; Carmen R Vargas; Guilhian Leipnitz; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

3.  Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; Helena Biasibetti-Brendler; Fernanda Silva Ferreira; Fernanda Dos Santos Petry; Vera Maria Treis Trindade; Regina Pessoa-Pureur; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2017-12-29       Impact factor: 3.584

4.  Neuroprotective Properties of Minocycline Against Methylphenidate-Induced Neurodegeneration: Possible Role of CREB/BDNF and Akt/GSK3 Signaling Pathways in Rat Hippocampus.

Authors:  Majid Motaghinejad; Manijeh Motevalian
Journal:  Neurotox Res       Date:  2022-04-21       Impact factor: 3.911

5.  Evidence That Methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks.

Authors:  Felipe Schmitz; Josiane S Silveira; Gianina T Venturin; Samuel Greggio; Guilherme Schu; Eduardo R Zimmer; Jaderson Costa Da Costa; Angela T S Wyse
Journal:  Neurotox Res       Date:  2021-11-19       Impact factor: 3.911

6.  The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial.

Authors:  Ludger Tebartz van Elst; Simon Maier; Stefan Klöppel; Erika Graf; Carola Killius; Marthe Rump; Esther Sobanski; Dieter Ebert; Mathias Berger; Andreas Warnke; Swantje Matthies; Evgeniy Perlov; Alexandra Philipsen
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

7.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

Review 8.  The Therapeutic Effect of the Chinese Herbal Medicine, Rehmanniae Radix Preparata, in Attention Deficit Hyperactivity Disorder via Reversal of Structural Abnormalities in the Cortex.

Authors:  Haixia Yuan; Meng Yang; Xinmin Han; Xinqiang Ni
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-14       Impact factor: 2.629

9.  Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts.

Authors:  Timothy A McCaffrey; Georges St Laurent; Dmitry Shtokalo; Denis Antonets; Yuri Vyatkin; Daniel Jones; Eleanor Battison; Joel T Nigg
Journal:  BMC Med Genomics       Date:  2020-10-28       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.